Filing Details
- Accession Number:
- 0001209191-10-008925
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-02-12 12:00:00
- Reporting Period:
- 2010-02-11
- Filing Date:
- 2010-02-12
- Accepted Time:
- 2010-02-12 15:45:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1028318 | Micrus Endovascular Corp | MEND | Surgical & Medical Instruments & Apparatus (3841) | 232853441 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1325284 | Jr F Edward Ruppel | 821 Fox Lane San Jose CA 95131 | Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-02-11 | 12,736 | $1.15 | 15,672 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-02-11 | 1,832 | $18.77 | 13,840 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-02-11 | 1,000 | $18.78 | 12,840 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-02-11 | 6,904 | $18.75 | 5,936 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-02-11 | 3,000 | $18.79 | 2,936 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2010-02-11 | 12,736 | $1.15 | 12,736 | $1.15 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-10-29 | No | 4 | M | Direct |
Footnotes
- This grant was initially reported on the reporting person's Form 3 report filed on June 15, 2005 and the exercise price was reflected at a rounded price of $1.15.
- This grant is fully vested and exercisable. The original vesting schedule was as follows: 1/4 vested at the one year anniversary, 1/48th of entire amount vested each month thereafter.